Anti-capsular immunity to Streptococcus pneumoniae serotype 22F prevents bacterial transmission in murine colonization and influenza virus co-infection models

Vaccine. 2021 Jan 15;39(3):469-472. doi: 10.1016/j.vaccine.2020.11.075. Epub 2020 Dec 19.

Abstract

We evaluated the effectiveness of anti-22F serotype immunity in the prevention of Streptococcus pneumoniae (Spn) bacterial transmission during colonization and influenza virus co-infection. Mice were immunized with 22F formulation and later colonized with Spn or co-infected with Spn and influenza virus. The 22F antisera exhibited strong reactivity to 22F bacteria and promoted the opsonic uptake of Spn by the neutrophils. The 22F vaccination led to a significant reduction of bacterial densities in the nasopharynx and prevented bacterial transmission during colonization and co-infection. The transfer of 22F antisera to infant mice resulted in reduced bacterial transmission in colonization and co-infection models.

Keywords: Co-infection; Inflammation; Influenza; Spn; Spn transmission; Upper respiratory infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coinfection* / prevention & control
  • Mice
  • Nasopharynx
  • Orthomyxoviridae*
  • Pneumococcal Infections* / prevention & control
  • Serogroup
  • Streptococcus pneumoniae